Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASI-A: Early IV vs Oral Iron for Anemia in Pregnancy
NCT04278651Phase 4Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2021
- Primary completion
- Aug 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferumoxytol in iron deficiency anemia (IDA) (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Change in Hemoglobin at 90 days. Started Sep 2021; status: recruiting.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04278651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04278651.